Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial

Author(s):
Schneider, T.C.; Abdulrahman, R.M.; Corssmit, E.P.; Morreau, H.; Smit, J.W.A. (0000-0002-6070-4865); Kapiteijn, E.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-11-30
Language
English
Is part of
European Journal of Endocrinology (2012), Vol. 167, no. 5, p. 643-650
hdl
1887/97966
doi
10.1530/EJE-12-0405